PRELUDE CAPITAL MANAGEMENT, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 178 filers reported holding HAEMONETICS CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$415,830
-25.7%
4,642
-47.6%
0.03%
+68.8%
Q1 2022$560,000
-40.6%
8,857
-33.7%
0.02%
-33.3%
Q3 2021$943,000
-9.8%
13,352
-14.9%
0.02%
-22.6%
Q2 2021$1,046,000
-58.9%
15,693
-31.5%
0.03%
-52.3%
Q1 2021$2,542,000
+23.5%
22,897
+32.1%
0.06%
+25.0%
Q4 2020$2,058,000
+350.3%
17,328
+230.9%
0.05%
+136.4%
Q3 2020$457,000
+7.8%
5,237
+10.7%
0.02%
-4.3%
Q2 2020$424,000
+3161.5%
4,731
+4162.2%
0.02%
Q4 2019$13,000
-89.7%
111
-97.5%
0.00%
-100.0%
Q2 2016$126,000
+75.0%
4,362
+171.8%
0.02%
+80.0%
Q1 2015$72,0001,6050.01%
Other shareholders
HAEMONETICS CORP shareholders Q2 2016
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders